A carregar...
Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients
A phase II study was undertaken to determine the safety of combining flutamide with gemcitabine, with response rate being the primary end point. Twenty-seven patients with histologically proven, previously untreated, unresectable pancreatic adenocarcinoma received gemcitabine, 1 g m(−2) intravenousl...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2002
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2364255/ https://ncbi.nlm.nih.gov/pubmed/12232752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600523 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|